Discover
Author: Xentech-Admin
Publications
Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification
Discover
Publications
Targeting genome integrity dysfunctions impedes metastatic potency in non-small-cell lung cancer circulating tumor cellderived eXplants
CTC-derived eXplants (CDX) offer systems for mechanistic investigation of CTC metastatic potency and may provide rationale for biology-driven therapeutics.
Discover
All our news
XenTech exhibits at AACR Annual Meeting (New Orleans, Apr.8-13 2022)
We’ll be exhibiting at AACR New Orleans from Apr.8th 2022, stop by our booth to chat with us (at last!)
Discover
Publications
STING protects breast cancer cells from intrinsic and genotoxic-induced DNA instability via a non-canonical, cell-autonomous pathway – Oncogene, Oct.8 2021
Discover
Conferences & events
XenTech live at AACR Spotlight Series
XenTech uncovers its unique dedication into PDX field to AACR attendees on Oct. 5th 2021
Discover
Conferences & events
XenTech will attend BIO-EUROPE
We’ll be delighted to present you the new products and services, reach out to us !
Discover
Conferences & events
XenTech will attend BIOPHARM-US
We’ll be delighted to present you the new products and services, reach out to us !
Discover